Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Cipla
Federal Trade Commission
Argus Health
Healthtrust

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for NOVA-22007

« Back to Dashboard

US Patents for NOVA-22007

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
NOVA-22007 ➤ Sign Up Methods for determining risk of chronic lung allograft dysfunction (CLAD) and subtypes thereof University Health Network (Toronto, CA) ➤ Sign Up
NOVA-22007 ➤ Sign Up Targeted poorly water-soluble drug delivery system, method of preparing the same, and pharmaceutical composition including the same SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, KR) ➤ Sign Up
NOVA-22007 ➤ Sign Up Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH) ➤ Sign Up
NOVA-22007 ➤ Sign Up Substituted indole Mcl-1 inhibitors Vanderbilt University (Nashville, TN) ➤ Sign Up
NOVA-22007 ➤ Sign Up Methods of treating colorectal cancer Nogra Pharma Limited (Dublin, IE) ➤ Sign Up
NOVA-22007 ➤ Sign Up Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist Ciba-Geigy Corporation (Ardsley, NY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for NOVA-22007

Drugname Country Document Number Estimated Expiration Related US Patent
NOVA-22007 Canada 2938893 2033-02-20 ➤ Sign Up
NOVA-22007 European Patent Office 2959017 2033-02-20 ➤ Sign Up
NOVA-22007 World Intellectual Property Organization (WIPO) 2014127463 2033-02-20 ➤ Sign Up
NOVA-22007 European Patent Office 2896401 2032-09-12 ➤ Sign Up
NOVA-22007 South Korea 101493930 2032-09-12 ➤ Sign Up
NOVA-22007 South Korea 20140036338 2032-09-12 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Merck
US Army
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.